Trust and Treatment
01/20/2006 12:00 am EST
While excelling at very short-term trading, providing detailed advice to subscribers several times each day, Mark Leibovit also uncovers longer-term core positions. Here he looks at gold, one of his favorite long-term markets, as well as a medical speculation.
"streetTRACKS Gold Trust (GLD NYSE) is an investment trust whose shares strive to reflect the performance of the price of gold bullion, less the trust’s expenses. The trust holds gold, and is expected to issue baskets in exchange for deposits of gold, and to distribute gold in connection with redemptions of baskets.
"The gold held by the trust will only be sold on an as-needed basis to pay trust expenses, in the event the trust terminates and liquidates its assets, or as otherwise required by law or regulation. The trust is not managed like an active investment vehicle, and it's not registered as an investment company under the Investment Company Act of 1940.
"Hythiam (HYTM NASDAQ), a development stage management company, engages in the research, development, licensing, and commercialization of physiological treatment protocols for the treatment of alcoholism and other substance. The company offers HANDS Protocols for use by healthcare providers to treat patients diagnosed with dependencies on alcohol, cocaine, methamphetamine, and other addictive stimulants, as well as combinations of these drugs.
"Its HANDS Protocols also provide a maintenance program that includes medications and incentives for patients to continue with their recovery process through individualized continuing care programs. The company also offers administrative services to assist physicians and facilities with staff education, clinical services, marketing and sales support, and outcomes tracking methodologies for data analysis. Our target for this more speculative idea is $10-$12."
We hold three biotech stocks in our growth portfolio — Biogen (BIIB), Bioverativ (BIVV), and R...
Under the guise of clamping down on “widespread corruption,” Prince Mohammed bin Salman ...